News Chart Virax Biolabs Group Limited

Equities

VRAX

KYG9495L1251

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 21/01/2026 GMT			5-day change	1st Jan Change
0.2730 ^USD	-4.55%		-11.94%	-21.05%

12-02	Virax Biolabs Group Limited announced that it expects to receive $5 million in funding	CI
12-02	Virax Biolabs Group Limited Reports Earnings Results for the Half Year Ended September 30, 2025	CI

529f2dd5da14e5612e5749e.VrZxXDZpRW2T6qCodaqFKxcrKHQOGw2hMPTOxbG7-1Q.N-4nOEUONjz0hezfPIf0UnIGaTpZL2OZHc2-tdnotRoM_zwDejovB9i4xw~212bda0fd90d07742a995070b8d5375e